Goldman Sachs has lost Michael Hill, a senior banker in its European pharmaceutical and biotech practice, to Citigroup, where he will become head of European healthcare.

Hill, who leaves Goldman Sachs after 11 years, most recently as a managing director, will replace Kevin Wilson, who has become a managing director of pharmaceuticals in Citigroup's equity research team.